	Transition-Specific Associations of Cardiometabolic Biomarker Burden With Cardio-Renal-Metabolic Multimorbidity Progression: A Multistate Cohort Study. Diabetes Obes Metab Li X, Peng J, Quan J, Zhang D, Chen L, Liu M, Zhang Y, Yi B, Huang Z. PMID: 42870539 [PubMed - as supplied by publisher]
	Prostate Cancer Therapy via Inhibition of Negative Immune Regulation. Biomed Res Int Dutta S, Sengupta P, Chowdhury U, Maldonado Rosas I, Kalita JC, Selvam MKP, Roychoudhury S. PMID: 42870457 [PubMed - indexed for MEDLINE]
	The Human Ovary Exhibits Dynamic Molecular Remodeling in the Decades Post-Menopause. Aging Cell Watson MA, Soygur B, King CD, Devrukhkar PR, Melov S, Shanes ED, Pavone MEG, Duncan FE, Schilling B. PMID: 42870449 [PubMed - indexed for MEDLINE]
	Impact of probiotic supplementation on serum klotho levels and inflammatory status in patients with diabetic kidney disease. Egypt J Immunol Mohamed AE, Abdel Mohsen WA, Abdelsattar HA, Hussein HA, Behairy MA, Saeed SA. PMID: 42870386 [PubMed - indexed for MEDLINE]
	Physical Activity Levels and Lung-Kidney Function in a Cohort of COVID-19 Survivors. Med Sci Sports Exerc Ribeiro HS, Mondini DR, Mattedi FZ, Gil S, Marçal L, Antonângelo L, Catharina GS, Yu L, Hallal PC, Damiano RF, Busatto GF, Carvalho CRR, Gualano B, Roschel H, Burdmann EA, HCFMUSP COVID-19 Study Group. PMID: 42870357 [PubMed - indexed for MEDLINE]
	What is the significance of intra-operative oliguria with regard to post-operative acute kidney injury? A physiology-informed framework for intra-operative oliguria management. J Anesth Analg Crit Care Blackwood L. PMID: 42870322 [PubMed]
	Liquid biopsy in bladder cancer: towards precision oncology. J Transl Med Chen C, Yang Y, Chen Z, Li X, Zhu Y, Zhai Y, Zheng J, Dai X, Zhou JG, Ma H, Ye X. PMID: 42870280 [PubMed - indexed for MEDLINE]
	Stage-dependent alterations in MaR1 in pediatric chronic kidney disease: a potential candidate biomarker. BMC Nephrol Guler MA, Celik M, Halici H, Bayraktutan Z, Yurdgulu EE, Ay YA, Keskin H. PMID: 42870244 [PubMed - indexed for MEDLINE]
	Timing of renal coordinator referral and risk of unplanned dialysis initiation in advanced chronic kidney disease: a retrospective cohort study. BMC Nephrol Tiew HW, Kong CMC, Renaud CJ, Teoh STY, Saifful SFBB, Ho JTZ, Lau SM, Tan GFL, Hsu JHY, Wong SY, Teh YK, Liu AYL. PMID: 42870239 [PubMed - indexed for MEDLINE]
	Higher APOB is associated with poor renal outcome in lupus nephritis. Clin Rheumatol Wang Q, Wu W, Jiang Z. PMID: 42870200 [PubMed - as supplied by publisher]
	Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial. Insights Imaging Greidanus J, Bernabei C, Chupetvloska K, Agrotis G, Mertens LS, van Rhijn BWG, van der Poel HG, van der Heijden MS, Beets-Tan RGH, Pizzi AD, Boellaard TN, Trebeschi S. PMID: 42870138 [PubMed]
	Thirty-day outcomes of Direct In-Scope Suction (DISS) in real-world practice using magneto, MOSES, and Thulium fiber laser technologies for renal and ureteral stones: an EAU endourology study. Urolithiasis Gauhar V, Castellani D, Fong KY, Rico L, Contreras P, Castillo CJG, Kwok JL, Emiliani E, Martinez BB, Tsaturyan A, Gadzhiev N, Malkhasyan V, El Hajj A, Kwan FHS, Cormio A, Güven S, Geavlete B, Becker B, Benjamin LTY, Zawadzki M, Pietropaolo A, Herrmann T, Yuen SKK, Somani B, Giulioni C. PMID: 42870008 [PubMed - indexed for MEDLINE]
	Fracture risk and fracture risk factor assessment among men at prostate cancer diagnosis. Prostate Cancer Prostatic Dis Shulman MJ, Darbinian JA, Chandra M, Harzstark AL, Lo JC. PMID: 42869964 [PubMed - as supplied by publisher]
	Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study. Eur Urol Focus Tan YG, Dudinec J, Kamat AM, Lim BJH, Ghoreifi A, Yuen JSP, Chen K, Kanesvaran R, Chan J, Shah AM, Tay KJ, Abern MR. PMID: 42869744 [PubMed - as supplied by publisher]
	Translational research models for variant subtype bladder cancers: A comprehensive review of the current landscape. Urol Oncol Nanjo GU, Fu Z, Smani S, Lokeshwar SD, Warrick J, Kumar D, Kim W, Perry CJ, Tan WS, Mu P, Martin DT, Ghali F. PMID: 42869701 [PubMed - as supplied by publisher]
	Response to "Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival". Urol Oncol Kohler J, Rodler S. PMID: 42869700 [PubMed - as supplied by publisher]
	Initial complete local therapy without systemic therapy versus systemic-therapy-based management in selected patients with oligometastatic renal cell carcinoma: a matched comparative study. Radiother Oncol Kim HU, Lee HI, Park I, Kim JK, Kim YJ. PMID: 42869248 [PubMed - as supplied by publisher]
	Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Multicenter Retrospective Study. J Natl Compr Canc Netw Gopalakrishnan D, Fujiwara Y, Collier KA, Park JJ, Zaemes JP, Lam ET, Alaklabi S, Jaeger EB, Barata PC, Kauffman EC, Atkins MB, Alva A, Yang Y, George S. PMID: 42869085 [PubMed - as supplied by publisher]
	[Molecular-Based Diagnostics and Therapy of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)]. Aktuelle Urol Kesch C, Hadaschik B, von Amsberg G. PMID: 42869040 [PubMed - as supplied by publisher]
	Adenoma laterality and risk of subsequent colorectal cancer: Secondary analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer trial. Surgery Frebault J, Troester A, Huo L, Rudser K, Hassan I, Shaukat A, Goffredo P. PMID: 42868921 [PubMed - as supplied by publisher]

Articles 1 - 20 / 482980

Page 1 of 24149



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy